Allergic Rhinitis – Current and Future Players

Pages: 82 Published: September 01, 2015 Report Code: GDHC1054FPR

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen

GlobalData has released its pharma report, “Allergic Rhinitis – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Allergic Rhinitis Market. The report identifies and analyses the key companies shaping and driving the global Allergic Rhinitis market. The report provides insight into the competitive Allergic Rhinitis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.


Investigation of current and future market competition for Allergic Rhinitis

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Allergic Rhinitis sector through market impact analysis, future market scenario and company analysis

Reasons to Buy

Gain a high level view of the trends shaping and driving Allergic Rhinitis market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What’s the next big thing in the global Allergic Rhinitis market landscape? Identify, understand and capitalize

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures



2.2Related Reports

2.3Upcoming Related Reports

3Market Outlook

3.1Global Markets


3.1.2Drivers and Barriers – Global Issues

4Current and Future Players


4.2Trends in Corporate Strategy

4.3Major Companies

4.3.1Merck & Co.


4.3.3Sumitomo Dainippon Pharma



4.3.6Meda AB





5.4Forecasting Methodology

5.4.1Pediatric Allergic Rhinitis Population

5.4.2Diagnosed AR Patients

5.4.3Percentage of Drug-Treated Patients

5.4.4Drugs Included in Each Therapeutic Class

5.4.5Launch and Patent Expiry Dates

5.4.61General Pricing Assumptions

5.4.7Individual Drug Assumptions

5.4.8Generic Erosion

5.4.9Pricing of Pipeline Agents

5.5Physicians and Specialists Included in This Study

5.6About the Authors


5.6.2Therapy Area Director


5.6.4Global Head of Healthcare

5.7About GlobalData


List of Tables

Table 1: Global Sales Forecasts ($m) for AR, 2014–2024

Table 2: Global AR Market – Drivers and Barriers, 2014–2024

Table 3: Major Companies in the AR Market and Their Portfolios, 2014

Table 4: Merck’s AR Portfolio Assessment, 2014

Table 5: GSK’s AR Portfolio Assessment, 2014

Table 6: Sumitomo Dainippon Pharma’s AR Portfolio Assessment, 2014

Table 7: Sanofi’s AR Portfolio Assessment, 2014

Table 8: Teva’s AR Portfolio Assessment, 2014

Table 9: Meda’s AR Portfolio Assessment, 2014

Table 10: Abbreviations

Table 11: Key Launch Dates of the Currently Available AR Therapies

Table 12: Key Loss of Exclusivity Dates of the Currently Available AR Therapies

Table 13: High-Prescribing Physicians (non-KOLs) Surveyed, by Country

List of Figures

Figure 1: Global Sales for AR by Region, 2014–2024

Figure 2: Company Portfolio Gap Analysis in AR, 2014–2024


Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.